Genetically altered herpesviruses as vaccines

Area of Science:

• Veterinary Virology
• Animal Health
• Vaccine Technology

Background:

• Herpesviruses are significant pathogens in domestic animals, causing various diseases.
• Conventional vaccines have limitations in controlling herpesvirus infections and eradication campaigns.
• Genetically modified vaccines present improved characteristics for disease management.

Purpose of the Study:

• To evaluate the advantages of genetically modified vaccines over conventional vaccines for animal herpesvirus diseases.
• To discuss the limitations of current vaccine strategies in preventing super-infection and facilitating eradication.
• To explore novel approaches for preventing herpesvirus infections in animals.

Main Methods:

• Review of existing literature on herpesvirus diseases and vaccine efficacy.
• Comparative analysis of conventional and genetically modified vaccine attributes.
• Discussion of challenges in disease eradication, including super-infection and environmental contamination.
• Exploration of future strategies, such as transgenic animals, for disease prevention.

Main Results:

• Genetically modified vaccines exhibit reduced virulence and latency compared to conventional vaccines.
• These vaccines possess markers for differentiating vaccine strains from wild-type viruses and vaccinated from infected animals.
• Benefits are particularly noted in eradication programs for diseases like Aujeszky's disease and infectious bovine rhinotracheitis.
• Neither vaccine type prevents super-infection, posing challenges for diseases like Marek's disease.

Conclusions:

• Genetically modified vaccines offer significant improvements for controlling herpesvirus diseases in animals.
• The inability to prevent super-infection remains a critical limitation for eradication efforts.
• Development of new strategies, such as innate resistance through transgenic animals, is crucial for future disease control.